Currently, no company worldwide has completed the required oral toxicity studies, metabolism studies, and long-term safety evaluations for GHK-Cu and submitted a GRAS notification to the FDA
Find out if a low-carb diet, such as the Mediterranean diet, or lifestyle changes help with gastroesophageal reflux disease (GERD)
The 10 Stages Clinical Safety Screens Performed MTC & MEN2 contraindications screened three separate times across the flow Dedicated eating disorder screen Anorexia Nervosa, Bulimia Nervosa, purging, laxative use Mental health hospitalization depression, bipolar disorder, schizophrenia history Suicidal ideation dedicated standalone screen Organ function kidneys, liver, and cardiac function each get their own screen Comorbidity multi-select diabetes, hypertension, heart disease, thyroid, asthma/COPD, anxiety, depression, HIV/AIDS, and more Pancreatitis & thyroid cancer individual confirmation screens in addition to multi-select Comprehensive family history FDA-specific (MEN2/MTC) plus cardiovascular, metabolic, and Long QT syndrome Injection safety prior injection experience, past injection problems, and comfort with self-administration three separate screens Reproductive status 8-option screen including pregnancy intent and breastfeeding AgelessRx does not use a validated PHQ-2 or PHQ-9 depression screening tool mental health is addressed through a hospitalization history question rather than a clinical screen
Without that foundation, none of the other optimizations matter
Check Your Eligibility Free Consultation (Prospective Patients) Starting July 1, 2026 , Medicare Part D covers Wegovy, Zepbound, and Foundayo for weight loss through the new GLP-1 Bridge program
